Αποτελέσματα Αναζήτησης
10 Ιαν 2022 · Alzheimer’s disease is associated with impairments in emotional communication including comprehension and production of facial emotional expressions, comprehension of affective prosody, and alexithymia.
- Deficits in emotion processing in Alzheimer’s disease: a systematic ...
There is no consensus about how Alzheimer’s disease (AD)...
- Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of ...
The findings suggest prominent deficit in recognizing...
- Deficits in emotion processing in Alzheimer’s disease: a systematic ...
5 ημέρες πριν · There is no consensus about how Alzheimer’s disease (AD) affects emotional processing. Objective: Our aim is to systematically review the impact of AD on emotion processing. Methods: We conducted a search based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
31 Μαρ 2022 · The findings suggest prominent deficit in recognizing negative emotions, pronounced effect of positive emotion on enhancing memory, and a critical role of cognitive deficits in manifesting emotional processing dysfunction in AD.
6 Ιουν 2019 · Two meta-analyses indicated some efficacy regarding the use of Alzheimer's disease medications for the improvement of BPSD. One by Trinh et al. reported that cholinesterase inhibitors produced modest improvements in neuropsychiatric and functional outcomes, compared with placebo.
31 Ιαν 2013 · Symptom clusters can also be targeted by combining medications such as a cholinesterase inhibitor with an antipsychotic, an antipsychotic with an antidepressant or an antidepressant with a hypnotic drug.
The findings suggest prominent deficit in recognizing negative emotions, pronounced effect of positive emotion on enhancing memory, and a critical role of cognitive deficits in manifesting emotional processing dysfunction in AD.
9 Ιαν 2023 · Depression in dementia is common, disabling and causes significant distress to patients and carers. Despite widespread use of antidepressants for depression in dementia, there is no evidence of therapeutic efficacy, and their use is potentially harmful in this patient group.
